Loading...
Stem cell bioengineering with bioportides: inhibition of planarian head regeneration with peptide mimetics of eyes absent proteins
Jones, Sarah Matos, Bárbara Dennison, Sarah Fardilha, Margarida Howl, John
Jones, Sarah
Matos, Bárbara
Dennison, Sarah
Fardilha, Margarida
Howl, John
Editors
Other contributors
Epub Date
Issue Date
2023-07-26
Submitted date
Files
Alternative
Abstract
Djeya1 (RKLAFRYRRIKELYNSYR) is a very effective cell penetrating peptide (CPP) that mimics the α5 helix of the highly conserved Eya domain (ED) of eyes absent (Eya) proteins. The objective of this study was to bioengineer analogues of Djeya1 that, following effective translocation into planarian tissues, would reduce the ability of neoblasts (totipotent stem cells) and their progeny to regenerate the anterior pole in decapitated S. mediterranea. As a strategy to increase the propensity for helix formation, molecular bioengineering of Djeya1 was achieved by the mono-substitution of the helicogenic aminoisobutyric acid (Aib) at three species-variable sites: 10, 13, and 16. CD analyses indicated that Djeya1 is highly helical, and that Aib-substitution had subtle influences upon the secondary structures of bioengineered analogues. Aib-substituted Djeya1 analogues are highly efficient CPPs, devoid of influence upon cell viability or proliferation. All three peptides increase the migration of PC-3 cells, a prostate cancer line that expresses high concentrations of Eya. Two peptides, [Aib13]Djeya1 and [Aib16]Djeya1, are bioportides which delay planarian head regeneration. As neoblasts are the only cell population capable of division in planaria, these data indicate that bioportide technologies could be utilised to directly manipulate other stem cells in situ, thus negating any requirement for genetic manipulation.
Citation
Jones, S., Matos, B., Dennison, S., Fardilha, M., & Howl, J. (2023). Stem Cell Bioengineering with Bioportides: Inhibition of Planarian Head Regeneration with Peptide Mimetics of Eyes Absent Proteins. Pharmaceutics, 15(8), Article Number 2018. Retrieved from http://dx.doi.org/10.3390/pharmaceutics15082018
Publisher
Journal
Research Unit
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
© 2023 The Authors. Published by MDPI AG. This is an open access article available under a Creative Commons licence.
The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.3390/pharmaceutics15082018
Series/Report no.
ISSN
1999-4923
EISSN
1999-4923
ISBN
ISMN
Gov't Doc #
Sponsors
Bárbara Matos was supported by an individual grant from the Portuguese Foundation for Science and Technology (FCT), grant identifier SFRH/BD/146032/2019.